However, these findings are controversial, with some counter studies suggesting that there is no link between increased circulating RBP4 and insulin resistance, type 2 diabetes, and NAFLD [20,24]. The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.